Literature DB >> 27439214

Irgm1 promotes M1 but not M2 macrophage polarization in atherosclerosis pathogenesis and development.

Shaohong Fang1, Yanwen Xu2, Yun Zhang2, Jiangtian Tian1, Ji Li1, Zhaoying Li2, Zhongze He2, Ruikai Chai2, Fang Liu2, Tongshuai Zhang2, Shuang Yang1, Chunying Pei3, Xinxin Liu1, Peng Lin2, Hongwei Xu3, Bo Yu1, Hulun Li4, Bo Sun5.   

Abstract

BACKGROUND AND AIMS: Atherosclerosis is a chronic inflammatory vascular disease related to macrophages uptake of low-density lipoprotein and their subsequent transformation into foam cells. M1 (inflammatory)/M2 (anti-inflammatory) balance was suggested to impact disease progression. In this study, we investigated whether the immunity related GTPase (Irgm1) regulates macrophage polarization during atherosclerosis development.
METHODS: We used apolipoprotein E (ApoE) knockout and Irgm1 haplodeficient mice and induced atherosclerosis with high-cholesterol diet for the indicated months. Atherosclerotic arteries were collected from patients undergoing vascular surgery, to determine the lesional expression of Irgm1 and distribution of M1/M2 populations.
RESULTS: Our results showed that IRGM/Irgm1 expression was increased in atherosclerotic artery samples (1.7-fold, p=0.0045) compared with non-atherosclerotic arteries, which was consistent with findings in the murine experimental atherosclerosis model (1.9-fold, p=0.0002). IRGM/Irgm1 expression was mostly found in lesional M1 macrophages. Haplodeficiency of Irgm1 in ApoE(-/-) mice resulted in reduced infiltrating M1 macrophages in atheroma (94%, p=0.0002) and delayed development of atherosclerotic plaques. In vitro experiments also confirmed that Irgm1 haplodeficiency reduced iNOS expression of polarized M1 macrophages (81%, p=0.0034), with negligible impact on the M2 phenotype. Moreover, we found that Irgm1 haplodeficiency in mice significantly reduced expression level of M1 function-related transcription factors, interferon regulatory factor (Irf) 5 and Irf8, but not Irf4, an M2-related transcription factor.
CONCLUSIONS: This study shows that Irgm1/IRGM participates in the polarization of M1 macrophage and promotes development of atheroma in murine experimental atherosclerosis.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; IRGM/Irgm1; Macrophage; Polarization

Mesh:

Substances:

Year:  2016        PMID: 27439214     DOI: 10.1016/j.atherosclerosis.2016.07.011

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  17 in total

1.  AtheroSpectrum Reveals Novel Macrophage Foam Cell Gene Signatures Associated With Atherosclerotic Cardiovascular Disease Risk.

Authors:  Chuan Li; Lili Qu; Alyssa J Matz; Patrick A Murphy; Yongmei Liu; Ani W Manichaikul; Derek Aguiar; Stephen S Rich; David M Herrington; David Vu; W Craig Johnson; Jerome I Rotter; Wendy S Post; Anthony T Vella; Annabelle Rodriguez-Oquendo; Beiyan Zhou
Journal:  Circulation       Date:  2021-12-16       Impact factor: 29.690

Review 2.  CTRP family in diseases associated with inflammation and metabolism: molecular mechanisms and clinical implication.

Authors:  Huan Zhang; Zi-Yin Zhang-Sun; Cheng-Xu Xue; Xi-Yang Li; Jun Ren; Yu-Ting Jiang; Tong Liu; Hai-Rong Yao; Juan Zhang; Tian-Tian Gou; Ye Tian; Wang-Rui Lei; Yang Yang
Journal:  Acta Pharmacol Sin       Date:  2022-10-07       Impact factor: 7.169

3.  Macrophage depletion by clodronate attenuates bone morphogenetic protein-7 induced M2 macrophage differentiation and improved systolic blood velocity in atherosclerosis.

Authors:  Heidi Shoulders; Kaley H Garner; Dinender K Singla
Journal:  Transl Res       Date:  2018-07-25       Impact factor: 7.012

Review 4.  Modulators of the Balance between M1 and M2 Macrophages during Pregnancy.

Authors:  Yong-Hong Zhang; Ming He; Yan Wang; Ai-Hua Liao
Journal:  Front Immunol       Date:  2017-02-09       Impact factor: 7.561

5.  Atheroregressive Potential of the Treatment with a Chimeric Monoclonal Antibody against Sulfated Glycosaminoglycans on Pre-existing Lesions in Apolipoprotein E-Deficient Mice.

Authors:  Victor Brito; Katia Mellal; Karina F Zoccal; Yosdel Soto; Liliane Ménard; Roger Sarduy; Lucia H Faccioli; Huy Ong; Ana M Vázquez; Sylvie Marleau
Journal:  Front Pharmacol       Date:  2017-11-01       Impact factor: 5.810

6.  Macrophage-derived foam cells impair endothelial barrier function by inducing endothelial-mesenchymal transition via CCL-4.

Authors:  Ying Yang; Nian-Sang Luo; Ru Ying; Yong Xie; Jia-Yuan Chen; Xiao-Qiao Wang; Zhen-Jie Gu; Jing-Ting Mai; Wen-Hao Liu; Mao-Xiong Wu; Zhi-Teng Chen; Yong-Biao Fang; Hai-Feng Zhang; Zhi-Yi Zuo; Jing-Feng Wang; Yang-Xin Chen
Journal:  Int J Mol Med       Date:  2017-06-19       Impact factor: 4.101

7.  Adipose-Derived Exosomes Exert Proatherogenic Effects by Regulating Macrophage Foam Cell Formation and Polarization.

Authors:  Zulong Xie; Xuedong Wang; Xinxin Liu; Huaan Du; Changbin Sun; Xin Shao; Jiangtian Tian; Xia Gu; Hailong Wang; Jinwei Tian; Bo Yu
Journal:  J Am Heart Assoc       Date:  2018-03-03       Impact factor: 5.501

Review 8.  Chemopreventive Effects of Phytochemicals and Medicines on M1/M2 Polarized Macrophage Role in Inflammation-Related Diseases.

Authors:  Yen-Chun Koh; Guliang Yang; Ching-Shu Lai; Monthana Weerawatanakorn; Min-Hsiung Pan
Journal:  Int J Mol Sci       Date:  2018-07-28       Impact factor: 5.923

9.  Viperin Deficiency Promotes Polarization of Macrophages and Secretion of M1 and M2 Cytokines.

Authors:  John Eom; Jihye Yoo; Jeong Jin Kim; Jae Bong Lee; Wanho Choi; Chae Gyu Park; Jun-Young Seo
Journal:  Immune Netw       Date:  2018-08-23       Impact factor: 6.303

Review 10.  Targeted inhibition of STAT3 as a potential treatment strategy for atherosclerosis.

Authors:  Qi Chen; Jianjun Lv; Wenwen Yang; Baoping Xu; Zheng Wang; Zihao Yu; Jiawei Wu; Yang Yang; Yuehu Han
Journal:  Theranostics       Date:  2019-08-14       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.